Imbruvica (Ibrutinib) is indicated for the treatment of patients with: Mantle cell lymphoma (MCL) who have received at least one prior therapy.
PROTEIN KINASE INHIBITORS
Create Personal Medication Record
Not a member? Sign up
Thanks for reporting a side effect for this drug.
Thanks for reporting the effectiveness of this drug.
Create your Personal Medication Record.